PRAC cautions use of Lemtrada, Xeljanz in latest meeting
admin 1st November 2019 Uncategorised 0Pfizer’s Xeljanz could potentially increase the risk of blood clots.
More: PRAC cautions use of Lemtrada, Xeljanz in latest meeting
Source: News
Pfizer’s Xeljanz could potentially increase the risk of blood clots.
More: PRAC cautions use of Lemtrada, Xeljanz in latest meeting
Source: News
© 1994 - 2026 B.M. Pharmaceuticals